+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain



In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain



Life Sciences 37(7): 657-664



The binding of 125I-LSD (2-[125I]-lysergic acid diethylamide) was studied in various mouse brain regions following intravenous injection of the radioligand. The high specific activity of 125I-LSD enabled the injection of low mass doses (14 ng/kg), which are well below the threshold for induction of any known physiological effect of the probe. The highest levels of 125I-LSD binding were found in the frontal cortex, olfactory tubercles, extra-frontal cortex and striatum while the lowest level was found in the cerebellum. Binding was saturable in the frontal cortex but increased linearly in the cerebellum with increasing doses of 125I-LSD. Serotonergic compounds potently inhibited 125I-LSD binding in cortical regions, olfactory tubercles, and hypothalamus but had no effect in the cerebellum. Dopaminergic compounds caused partial inhibition of binding in the striatum while adrenergic compounds were inactive. From these studies we conclude that 125I-LSD labels serotonin 5-HT2 receptor sites in cortical regions with no indication that other receptor sites are labeled. In the olfactory tubercles and hypothalamus, 125I-LSD labeling occurs predominantly or entirely at serotonin 5-HT2 sites. In the striatum, 125I-LSD labels approximately equal proportions of serotonergic and dopaminergic sites. This data indicates that 125I-LSD labels serotonin receptors in vivo and suggests that appropriate derivatives of 2I-LSD may prove useful for tomographic imaging of serotonin 5-HT2 receptors in the mammalian cortex.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040395198

Download citation: RISBibTeXText

PMID: 3160905

DOI: 10.1016/0024-3205(85)90433-3


Related references

In vivo binding of [125I]NH2-carfentanil to mu opioid receptors in mouse brain. Nuclear Medicine and Biology 21(2): 231-238, 1994

In vivo binding of iodine 125 labeled lsd to serotonin 5 hydroxytryptamine 2 and dopamine d 2 receptors in mouse brain. Society For Neuroscience Abstracts: 224, 1984

Selective in vitro and in vivo binding of (125I)ADAM to serotonin transporters in rat brain. Synapse (New York) 38(4): 403-412, 2000

Specific in vivo binding of [125I]-iodomelatonin to melatonin receptors in rat brain. Neuropharmacology 29(6): 603-608, 1990

Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin. European Journal of Pharmacology 145(2): 213-216, 1988

In vivo serotonin transporter binding characteristics of selective serotonin reuptake inhibitors in mouse brain. Journal of Pharmacological Sciences 91(Suppl. I): 92P, 2003

Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivo. Nuclear Medicine and Biology 23(3): 211-219, 1996

Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 22(2): 397-410, 1998

Characterization of desamino-5-(125I)Iodo-3-Methoxy-Zacopride ((125I)MIZAC) binding to 5-HT3 receptors in the rat brain. Progress in Neuro Psychopharmacology and Biological Psychiatry 22(2): 397-410, 1998

Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics 255(2): 843-857, 1990

Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology 24(5): 389-393, 1997

125I alpha - conotoxin MII membrane binding reveals the pharmacology of a subset of nicotinic acetylcholine receptors in mouse brain. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 158 13, 2003

In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain. European Journal of Pharmacology 81(1): 43-48, 1982

Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding. Brain Research 743(1-2): 178-183, 1996

Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents. Japanese Journal of Pharmacology 52(2): 195-200, 1990